Search research articles
Contact Us
Filters
Showing results (1-10 of 97) with videos related to
Page
of 10
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
January 24, 2004
[Evaluation of carotid artery lesion by echography]
Yoshimitsu Yamasaki
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
November 8, 2006
[Strategy for order-made treatment of diabetic macroangiopathy]
Yoshimitsu Yamasaki, Naoto Katakami
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 8, 2010
[Recent advance in genetic marker for diabetic macroangiopathy]
Yoshimitsu Yamasaki, Naoto Katakami
Stroke
|
August 5, 2006
Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus
Hiroki Yokoyama, Naoto Katakami, Yoshimitsu Yamasaki
Cardiovascular Diabetology
|
August 24, 2006
Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)
Yoshimitsu Yamasaki, Young-Seol Kim, Ryuzo Kawamori
Diabetes Research and Clinical Practice
|
May 6, 2008
Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy
Naoto Katakami, Hideaki Kaneto, Yoshimitsu Yamasaki, et al.
Nuclear Medicine Communications
|
February 5, 2013
Prognostic value of myocardial perfusion imaging for cardiovascular events among asymptomatic Japanese patients with type 2 diabetes and mild renal dysfunction
Chio Okuyama, Kenichi Nakajima, Yoshimitsu Yamasaki, et al.
Circulation
|
June 3, 2010
The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial
Naoto Katakami, Young-Seol Kim, Ryuzo Kawamori, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 1, 2012
Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study
Kenichi Nakajima, Yasuchika Takeishi, Shinro Matsuo, et al.
Diabetes Research and Clinical Practice
|
January 25, 2011
Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients
Naoto Katakami, Hideaki Kaneto, Munehide Matsuhisa, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 97) with videos related to
Sort By:
Page
of 10
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
January 24, 2004
[Evaluation of carotid artery lesion by echography]
Yoshimitsu Yamasaki
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
November 8, 2006
[Strategy for order-made treatment of diabetic macroangiopathy]
Yoshimitsu Yamasaki, Naoto Katakami
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 8, 2010
[Recent advance in genetic marker for diabetic macroangiopathy]
Yoshimitsu Yamasaki, Naoto Katakami
Stroke
|
August 5, 2006
Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus
Hiroki Yokoyama, Naoto Katakami, Yoshimitsu Yamasaki
Cardiovascular Diabetology
|
August 24, 2006
Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)
Yoshimitsu Yamasaki, Young-Seol Kim, Ryuzo Kawamori
Diabetes Research and Clinical Practice
|
May 6, 2008
Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy
Naoto Katakami, Hideaki Kaneto, Yoshimitsu Yamasaki, et al.
Nuclear Medicine Communications
|
February 5, 2013
Prognostic value of myocardial perfusion imaging for cardiovascular events among asymptomatic Japanese patients with type 2 diabetes and mild renal dysfunction
Chio Okuyama, Kenichi Nakajima, Yoshimitsu Yamasaki, et al.
Circulation
|
June 3, 2010
The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial
Naoto Katakami, Young-Seol Kim, Ryuzo Kawamori, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
December 1, 2012
Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study
Kenichi Nakajima, Yasuchika Takeishi, Shinro Matsuo, et al.
Diabetes Research and Clinical Practice
|
January 25, 2011
Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients
Naoto Katakami, Hideaki Kaneto, Munehide Matsuhisa, et al.
Page
of 10